(Q46909934)

26 December 2017

title

Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting (English)

1 reference

26 December 2017

1 reference

1 reference

Prabhakaran S

1

1 reference

26 December 2017

Wells KR

2

1 reference

26 December 2017

Lee VH

3

1 reference

26 December 2017

Flaherty CA

4

1 reference

26 December 2017

Lopes DK

5

1 reference

26 December 2017

publication date

7 November 2007

1 reference

26 December 2017

American Journal of Neuroradiology

published in

1 reference

26 December 2017

volume

29

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

281-285

1 reference

26 December 2017

https://api.crossref.org/works/10.3174%2FAJNR.A0818

1 reference

Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan).

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

21 January 2018

Clopidogrel resistance?

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Thromboelastography detects inadequate response to abciximab therapy during stent-assisted cerebral aneurysm coil embolization complicated by stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Clopidogrel resistance: implications for coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Resistance to antiplatelet drugs: current status and future research

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Variability of response to clopidogrel: possible mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: Do we need more aggressive dosing regimens in unstable angina?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function — a flow cytometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Platelet inhibition by insulin is absent in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0818

21 January 2018

Identifiers

DOI

10.3174/AJNR.A0818

1 reference

26 December 2017

1 reference

26 December 2017